Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

MAIA Biotechnology, Inc. (MAIA)

3.25   -0.14 (-4.13%) 09-24 15:43
Open: 3.4 Pre. Close: 3.39
High: 3.795 Low: 3.25
Volume: 67,401 Market Cap: 36(M)
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.8 - 3.82 3.82 - 3.85
Low: 3.2 - 3.22 3.22 - 3.24
Close: 3.21 - 3.25 3.25 - 3.29

Technical analysis

as of: 2022-09-23 4:25:44 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.4     One year: 6.4
Support: Support1: 3.25    Support2: 2.7
Resistance: Resistance1: 4.62    Resistance2: 5.48
Pivot: 3.76
Moving Average: MA(5): 3.39     MA(20): 3.81
MA(100): 0     MA(250): 0
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 7.8     %D(3): 7.8
RSI: RSI(14): 36.1
52-week: High: 9.64  Low: 3.25
Average Vol(K): 3-Month: 0 (K)  10-Days: 119 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MAIA ] has closed above bottom band by 9.0%. Bollinger Bands are 0% narrower than normal.

Headline News

Fri, 23 Sep 2022
“Peace will come” - The Asbury Collegian

Fri, 23 Sep 2022
Kudermetova holds off Haddad Maia, to face Zheng Qinwen in Tokyo semifinals - WTA Tennis

Thu, 22 Sep 2022
Ursula von der Leyen meets Maia Sandu and Svyatlana Tsihanouskaya in New York - EU NEIGHBOURS east - euneighbourseast.eu

Thu, 22 Sep 2022
Osaka withdraws from Tokyo; Haddad Maia through to quarterfinals - WTA Tennis

Wed, 21 Sep 2022
Prime Minister Justin Trudeau meets with President of Moldova Maia Sandu - Prime Minister of Canada

Wed, 21 Sep 2022
WTA Tokyo Day 4 Predictions Including Naomi Osaka vs Beatriz Haddad Maia - Last Word On Sports

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 0 (%)
% Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS 0
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.